Literature DB >> 32841431

Cold non-ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig-to-baboon xenotransplantation.

Matthias Längin1, Bruno Reichart2, Stig Steen3, Trygve Sjöberg3, Audrius Paskevicius3, Qiuming Liao3, Guangqi Qin3, Maren Mokelke2, Tanja Mayr1, Julia Radan2, Lara Issl2, Ines Buttgereit2, Jiawei Ying2, Ann Kathrin Fresch2, Alessandro Panelli2, Stefanie Egerer4, Andrea Bähr4, Barbara Kessler4, Anastasia Milusev5, Riccardo Sfriso5, Robert Rieben5, David Ayares6, Peter J Murray7, Reinhard Ellgass8, Christoph Walz9, Nikolai Klymiuk4, Eckhard Wolf4, Jan-Michael Abicht1, Paolo Brenner8.   

Abstract

BACKGROUND: Successful preclinical transplantations of porcine hearts into baboon recipients are required before commencing clinical trials. Despite years of research, over half of the orthotopic cardiac xenografts were lost during the first 48 hours after transplantation, primarily caused by perioperative cardiac xenograft dysfunction (PCXD). To decrease the rate of PCXD, we adopted a preservation technique of cold non-ischemic perfusion for our ongoing pig-to-baboon cardiac xenotransplantation project.
METHODS: Fourteen orthotopic cardiac xenotransplantation experiments were carried out with genetically modified juvenile pigs (GGTA1- KO/hCD46/hTBM) as donors and captive-bred baboons as recipients. Organ preservation was compared according to the two techniques applied: cold static ischemic cardioplegia (IC; n = 5) and cold non-ischemic continuous perfusion (CP; n = 9) with an oxygenated albumin-containing hyperoncotic cardioplegic solution containing nutrients, erythrocytes and hormones. Prior to surgery, we measured serum levels of preformed anti-non-Gal-antibodies. During surgery, hemodynamic parameters were monitored with transpulmonary thermodilution. Central venous blood gas analyses were taken at regular intervals to estimate oxygen extraction, as well as lactate production. After surgery, we measured troponine T and serum parameters of the recipient's kidney, liver and coagulation functions.
RESULTS: In porcine grafts preserved with IC, we found significantly depressed systolic cardiac function after transplantation which did not recover despite increasing inotropic support. Postoperative oxygen extraction and lactate production were significantly increased. Troponin T, creatinine, aspartate aminotransferase levels were pathologically high, whereas prothrombin ratios were abnormally low. In three of five IC experiments, PCXD developed within 24 hours. By contrast, all nine hearts preserved with CP retained fully preserved systolic function, none showed any signs of PCXD. Oxygen extraction was within normal ranges; serum lactate as well as parameters of organ functions were only mildly elevated. Preformed anti-non-Gal-antibodies were similar in recipients receiving grafts from either IC or CP preservation.
CONCLUSIONS: While standard ischemic cardioplegia solutions have been used with great success in human allotransplantation over many years, our data indicate that they are insufficient for preservation of porcine hearts transplanted into baboons: Ischemic storage caused severe impairment of cardiac function and decreased tissue oxygen supply, leading to multi-organ failure in more than half of the xenotransplantation experiments. In contrast, cold non-ischemic heart preservation with continuous perfusion reliably prevented early graft failure. Consistent survival in the perioperative phase is a prerequisite for preclinical long-term results after cardiac xenotransplantation.
© 2020 The Authors. Xenotransplantation published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac transplantation; heart preservation; perioperative cardiac xenograft dysfunction; xenotransplantation

Year:  2020        PMID: 32841431     DOI: 10.1111/xen.12636

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  7 in total

Review 1.  Evolution of Xenotransplantation as an Alternative to Shortage of Donors in Heart Transplantation.

Authors:  Ishaq J Wadiwala; Pankaj Garg; John H Yazji; Emad Alamouti-Fard; Mohammad Alomari; Md Walid Akram Hussain; Mohamed S Elawady; Samuel Jacob
Journal:  Cureus       Date:  2022-06-24

2.  The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donors.

Authors:  Corbin E Goerlich; Bartley Griffith; Peter Hanna; Susie N Hong; David Ayares; Avneesh K Singh; Muhammad M Mohiuddin
Journal:  J Thorac Cardiovasc Surg       Date:  2021-09-04       Impact factor: 5.209

Review 3.  Minimizing Ischemia Reperfusion Injury in Xenotransplantation.

Authors:  Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

Review 4.  Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights.

Authors:  Delphine Kervella; Stéphanie Le Bas-Bernardet; Sarah Bruneau; Gilles Blancho
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

Review 5.  Cardiac Xenotransplantation: Challenges, Evolution, and Advances.

Authors:  Jacinthe Boulet; Jonathan W Cunningham; Mandeep R Mehra
Journal:  JACC Basic Transl Sci       Date:  2022-06-15

Review 6.  Heart Donation and Preservation: Historical Perspectives, Current Technologies, and Future Directions.

Authors:  Nicholas R Hess; Luke A Ziegler; David J Kaczorowski
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

7.  Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation.

Authors:  Corbin E Goerlich; Bartley Griffith; Avneesh K Singh; Mohamed Abdullah; Shreya Singireddy; Irina Kolesnik; Billeta Lewis; Faith Sentz; Ivan Tatarov; Alena Hershfeld; Tianshu Zhang; Erik Strauss; Patrick Odonkor; Brittney Williams; Ali Tabatabai; Adnan Bhutta; David Ayares; David J Kaczorowski; Muhammad M Mohiuddin
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.